Evidence map›Paper›PMID 30504279›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2019

Claudin-1-Dependent Destabilization of the Blood-Brain Barrier in Chronic Stroke.

Nikola Sladojevic, Svetlana M Stamatovic, Allison M Johnson, Jennifer Choi, Anna Hu, Sophie Dithmer, Ingolf E Blasig, Richard F Keep, Anuska V Andjelkovic

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 85 papers.

0numbers the graph read from it
0cells of the map it votes in
85citing papers in PubMed
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

85 citing papers in PubMed, 143 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Nutrients · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Differential vulnerability among cell types in the neurovascular unit: Description and mechanisms.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2025
    Review

25 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Nikola SladojevicDepartment of Pathology.
Svetlana M StamatovicDepartment of Pathology.
Allison M JohnsonDepartment of Pathology.
Jennifer ChoiDepartment of Pathology.
Anna HuDepartment of Pathology.
Sophie DithmerLeibniz-Institut für Molekulare Pharmakologie, Berlin 13125, Germany.
Ingolf E BlasigLeibniz-Institut für Molekulare Pharmakologie, Berlin 13125, Germany.
Richard F KeepDepartment of Neurosurgery.ORCID 0000-0001-6441-5334
Anuska V AndjelkovicDepartment of Pathology, anuskaa@med.umich.edu.ORCID 0000-0001-8365-8016
Leibniz-Forschungsinstitut für Molekulare Pharmakologie · DEUman National University of Horticulture · UAUniversity of Michigan · US

Funding

Claudin Expression Profiles and Blood Brain Barrier in AgingRF1AG057928 · NIA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ANDJELKOVIC-ZOCHOWSKA, ANUSKA V. · 2017 to 2017
$2.3M
The blood brain barrier in neuroinflammationR01NS062853 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ANDJELKOVIC-ZOCHOWSKA, ANUSKA V. · 2009 to 2010
$660k
Influence of Brain Inflammation on the Occurrence of Embolic StrokeR21NS098211 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI STAMATOVIC, SVETLANA M · 2016 to 2017
$421k
Role of Cx43 signaling in cerebral cavernous malformation type-3 lesionR21NS098066 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ANDJELKOVIC-ZOCHOWSKA, ANUSKA V. · 2016 to 2017
$413k
Blood-Brain Barrier in NeuroinflammationR56NS062853 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ANDJELKOVIC-ZOCHOWSKA, ANUSKA V. · 2012 to 2012
$367k
NIA NIH HHS RF1 AG057928NINDS NIH HHS R01 NS062853NINDS NIH HHS R21 NS098066NINDS NIH HHS R21 NS098211NINDS NIH HHS R56 NS062853
6 · The paper itself

Abstract

Recent evidence suggests that blood-brain barrier (BBB) recovery and reestablishment of BBB impermeability after stroke is incomplete. This could influence stroke recovery, increase the risk of repeat stroke, and be a solid substrate for developing vascular dementia. Although accumulating evidence has defined morphological alterations and underlying mechanisms of tight junction (TJ) changes during BBB breakdown in acute stroke, very little is known about the type of alterations and mechanisms in BBB "leakage" found subacutely or chronically. The current study examined BBB structural alterations during the "BBB leakage" associated with the chronic phase of stroke in male mice and both genders of humans. We found significant upregulation of claudin-1 mRNA and protein, a nonspecific claudin for blood vessels, and downregulation in claudin-5 expression. Morphological and biochemical as well as fluorescence resonance energy transfer and fluorescence recovery after photobleaching analysis of postischemic brain endothelial cells and cells overexpressing claudin-1 indicated that newly synthesized claudin-1 was present on the cell membrane (∼45%), was incorporated into the TJ complex with established interaction with zonula occludens-1 (ZO-1), and was building homophilic

Indexed as

AnimalsBlood-Brain BarrierBrain IschemiaClaudin-1Claudin-5Down-RegulationEndothelial CellsFemaleHumansInfarction, Middle Cerebral ArteryInflammationMaleMiceStrokeTight JunctionsZonula Occludens-1 ProteinClaudin-1Claudin-5CLDN1 protein, humanCldn1 protein, mouseCLDN5 protein, humanCldn5 protein, mouseZonula Occludens-1 ProteinBBB recoverycerebrovascular injuryclaudin-1stroke

Identifiers

PMID30504279
PMCPMC6343646
OpenAlexW2903346602

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.